直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

Conference

AusMedtech 2016

May 10-11, 2016

Adelaide, Australia

AusBiotech

Finnegan attorney Bob Kramer will participate in the panel discussion “U.S. Patentable Subject Matter,” at Australia's Medtech Conference. The conference will examine the major factors in global medtech success, outline key commercial issues, and provide updates in the fields of IP, regulatory approvals, health economics, and sales networks. The conference will take place at the Adelaide Convention and Exhibition Center in Adelaide, Australia. For more information, or to register, please see the AusBiotech website.

Related Practices

Patent Drafting and Prosecution

Related Industries

Life Sciences

Medical Device and Diagnostics

Biotechnology

Related Professionals

Robert G. Kramer
Special Counsel
Washington, DC
+1 202 408 4000
+61 400 025 262
Email

Related Insights

Articles

EPR Academy, Part 5 of 6: Special Considerations for Third-Party Requesters

October 14, 2026

INCONTESTABLE® Blog

Federal Court Orders Rebel Creamery to Redesign Packaging and Disgorge $23.8 Million in Van Leeuwen Trade Dress Case

October 7, 2026

Articles

Trade Secret Litigation Checklist for Defendants

September/October 2026

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Articles

Why Fashion Brands are Doubling Down on US Utility Patents

Why Fashion Brands are Doubling Down on US Utility Patents

March 10, 2026

Articles

How the Timing of Hypothetical Negotiation Can Lead to a Higher Premium for Exclusivity

How the Timing of Hypothetical Negotiation Can Lead to a Higher Premium for Exclusivity

December/January 2026

Articles

Standing to Sue for Patent Infringement: Where Do We Stand on the “Exclusionary Right” Requirement?

November/December 2025

Articles

Thumbnail-G-1-24-Beyond-the-EPO

G1/24: Beyond the EPO

October 23, 2025

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP